会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Peptides whose uptake by cells is controllable
    • 细胞摄取的肽是可控的
    • US08642561B2
    • 2014-02-04
    • US13314134
    • 2011-12-07
    • Tao JiangRoger Y. Tsien
    • Tao JiangRoger Y. Tsien
    • A61K38/06A61K38/16A61K38/10G01N33/533C07H19/04G03F7/00
    • A61K49/0043A61K47/65A61K49/0056
    • A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases.
    • 本发明的肽的一般结构包括A-X-B-C,其中C是货物部分,B部分包括碱性氨基酸,X是可切割的接头序列,A部分包括酸性氨基酸。 完整结构不被细胞所占据; 然而,在X的细胞外裂解时,B-C部分被吸收,将货物运送到靶细胞。 货物可以是例如用于诊断成像的对比剂,化学治疗药物或用于治疗的放射线敏化剂。 X的裂解允许A与B分离,揭示B中碱性氨基酸的正常能力,将货物C拖入裂解事件附近的细胞。 X在细胞外裂解,优选在生理条件下。 对于A和B部分,D-氨基酸是优选的,以使由背景肽酶或蛋白酶的免疫原性和非特异性切割最小化。
    • 4. 发明申请
    • PEPTIDES WHOSE UPTAKE BY CELLS IS CONTROLLABLE
    • 细胞摄取的肽可以控制
    • US20110172139A1
    • 2011-07-14
    • US12244602
    • 2008-10-02
    • Tao JiangRoger Y. Tsien
    • Tao JiangRoger Y. Tsien
    • A61K38/02C07K2/00C12N9/96C12P21/06C07H21/00A61P35/00
    • A61K49/0043A61K47/65A61K49/0056
    • A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases.
    • 本发明的肽的一般结构包括A-X-B-C,其中C是货物部分,B部分包括碱性氨基酸,X是可切割的接头序列,A部分包括酸性氨基酸。 完整结构不被细胞所占据; 然而,在X的细胞外裂解时,B-C部分被吸收,将货物运送到靶细胞。 货物可以是例如用于诊断成像的对比剂,化学治疗药物或用于治疗的放射线敏化剂。 X的裂解允许A与B分离,揭示B中碱性氨基酸的正常能力,将货物C拖入裂解事件附近的细胞。 X在细胞外裂解,优选在生理条件下。 对于A和B部分,D-氨基酸是优选的,以使由背景肽酶或蛋白酶的免疫原性和非特异性切割最小化。
    • 5. 发明授权
    • Peptides whose uptake by cells is controllable
    • 细胞摄取的肽是可控的
    • US07431915B2
    • 2008-10-07
    • US10699562
    • 2003-10-31
    • Tao JiangRoger Y. Tsien
    • Tao JiangRoger Y. Tsien
    • A61K51/00A61M36/14
    • A61K49/0043A61K47/65A61K49/0056
    • A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases.
    • 本发明的肽的一般结构包括A-X-B-C,其中C是货物部分,B部分包括碱性氨基酸,X是可切割的接头序列,A部分包括酸性氨基酸。 完整结构不被细胞所占据; 然而,在X的细胞外裂解时,B-C部分被吸收,将货物运送到靶细胞。 货物可以是例如用于诊断成像的对比剂,化学治疗药物或用于治疗的放射线敏化剂。 X的裂解允许A与B分离,揭示B中碱性氨基酸的正常能力,将货物C拖入裂解事件附近的细胞。 X在细胞外裂解,优选在生理条件下。 对于A和B部分,D-氨基酸是优选的,以使由背景肽酶或蛋白酶的免疫原性和非特异性切割最小化。
    • 7. 发明申请
    • PEPTIDES WHOSE UPTAKE BY CELLS IS CONTROLLABLE
    • 细胞摄取的肽可以控制
    • US20120251445A1
    • 2012-10-04
    • US13314134
    • 2011-12-07
    • Tao JiangRoger Y. Tsien
    • Tao JiangRoger Y. Tsien
    • C12N5/071A61K49/00A61K51/08G01N27/72G01N23/00G01N21/64C12Q1/02A61K49/14B82Y15/00
    • A61K49/0043A61K47/65A61K49/0056
    • A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases.
    • 本发明的肽的一般结构包括A-X-B-C,其中C是货物部分,B部分包括碱性氨基酸,X是可切割的接头序列,A部分包括酸性氨基酸。 完整结构不被细胞所占据; 然而,在X的细胞外裂解时,B-C部分被吸收,将货物运送到靶细胞。 货物可以是例如用于诊断成像的对比剂,化学治疗药物或用于治疗的放射线敏化剂。 X的裂解允许A与B分离,揭示B中碱性氨基酸的正常能力,将货物C拖入裂解事件附近的细胞。 X在细胞外裂解,优选在生理条件下。 对于A和B部分,D-氨基酸是优选的,以使由背景肽酶或蛋白酶的免疫原性和非特异性切割最小化。
    • 8. 发明授权
    • Peptides whose uptake by cells is controllable
    • 细胞摄取的肽是可控的
    • US08110554B2
    • 2012-02-07
    • US12244602
    • 2008-10-02
    • Tao JiangRoger Y. Tsien
    • Tao JiangRoger Y. Tsien
    • A61K38/08A61K38/16G01N33/533C07H19/04G03F7/00
    • A61K49/0043A61K47/65A61K49/0056
    • A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. Cleavage of X allows separation of A from B, unmasking the normal ability of the basic amino acids in B to drag cargo C into cells near the cleavage event. X is cleaved extracellularly, preferably under physiological conditions. D-amino acids are preferred for the A and B portions, to minimize immunogenicity and nonspecific cleavage by background peptidases or proteases.
    • 本发明的肽的一般结构包括A-X-B-C,其中C是货物部分,B部分包括碱性氨基酸,X是可切割的接头序列,A部分包括酸性氨基酸。 完整结构不被细胞所占据; 然而,在X的细胞外裂解时,B-C部分被吸收,将货物运送到靶细胞。 货物可以是例如用于诊断成像的对比剂,化学治疗药物或用于治疗的放射线敏化剂。 X的裂解允许A与B分离,揭示B中碱性氨基酸的正常能力,将货物C拖入裂解事件附近的细胞。 X在细胞外裂解,优选在生理条件下。 对于A和B部分,D-氨基酸是优选的,以使由背景肽酶或蛋白酶的免疫原性和非特异性切割最小化。
    • 10. 发明授权
    • Feeding device
    • 送料装置
    • US09180993B2
    • 2015-11-10
    • US13482365
    • 2012-05-29
    • Jian-Bin ZhouChe-Yu ChouQun HuangTai-Shan ZhuTao JiangWei-Wei Yu
    • Jian-Bin ZhouChe-Yu ChouQun HuangTai-Shan ZhuTao JiangWei-Wei Yu
    • B65B39/00
    • B65B39/002B65B39/003B65B39/005B65B2220/14
    • A feeding device includes a material pipe, a first container, a second container and a constant-length linkage mechanism. The material pipe is configured for feeding a first material. The first container is configured for receiving the first material and supplying a timed amount of the first material to a first material feed port. The second container is configured for storing a second material and supplying the second material to a second material feed port. The constant-length linkage mechanism is connected to the first container and the second container. When the first container is actually supplying the first material to the first material feed port, the constant-length linkage mechanism allows the second container to supply the second material to the second material feed port simultaneously.
    • 进料装置包括材料管,第一容器,第二容器和恒定长度连杆机构。 材料管被配置为供给第一材料。 第一容器构造成用于接收第一材料并将定时量的第一材料供应到第一材料供给口。 第二容器构造成用于存储第二材料并将第二材料供应到第二材料进料口。 恒定连杆机构连接到第一容器和第二容器。 当第一容器实际上将第一材料供应到第一材料供给口时,恒定连杆机构允许第二容器同时将第二材料供应到第二材料进料口。